← Back to Search

Incentive Structure - fixed for Substance Abuse

N/A
Waitlist Available
Led By Laura Chavez
Research Sponsored by Nationwide Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
currently homeless, defined as lacking a fixed, regular, and adequate nighttime residence.
report any of the following past-month frequencies of substance use (NIDA ASSIST screen) used in prior EMA studies: a) heavy episodic or "binge" drinking (≥4 drinks per day for women/≥5 drinks for men) ≥2 days per month ; b) marijuana use ≥2 days per week; or c) any illicit drug use.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of trial (day 14)
Awards & highlights

Study Summary

This study is evaluating whether a mobile app can be used to collect data on substance use, mood, craving, and trauma in homeless youth.

Eligible Conditions
  • Substance Abuse

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of trial (day 14)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of trial (day 14) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of Time
Percent Completion

Trial Design

4Treatment groups
Experimental Treatment
Group I: EMA, 6x/day, prized-based incentiveExperimental Treatment2 Interventions
Ecological Momentary Assessment (EMA; Metricwire). Participants randomized to this group will be sent prompts through the EMA app to complete brief EMA survey at 6 random times per day. Participants randomized to this group will be rewarded for high survey completion with increasing numbers of "draws" for prizes depending on their level of response each week (50-74%=1 draw, 75-89%=2 draws, ≥90%=3 draws).
Group II: EMA, 6x/day, fixed incentiveExperimental Treatment2 Interventions
Ecological Momentary Assessment (EMA; Metricwire). Participants randomized to this group will be sent prompts through the EMA app to complete brief EMA survey at 6 random times per day. Participants randomized to this group will earn a fixed bonus/incentive based on completion of the EMA surveys (50-74%=$3; 75-89%=$5; ≥90%=$10) each week.
Group III: EMA, 3x/day, prize-based incentiveExperimental Treatment2 Interventions
Ecological Momentary Assessment (EMA; Metricwire). Participants randomized to this group will be sent prompts through the EMA app to complete brief EMA survey at 3 random times per day. Participants randomized to this group will be rewarded for high survey completion with increasing numbers of "draws" for prizes depending on their level of response each week (50-74%=1 draw, 75-89%=2 draws, ≥90%=3 draws).
Group IV: EMA, 3x/day, fixed incentiveExperimental Treatment2 Interventions
Ecological Momentary Assessment (EMA; Metricwire). Participants randomized to this group will be sent prompts through the EMA app to complete brief EMA survey at 3 random times per day. Participants randomized to this group will earn a fixed bonus/incentive based on completion of the EMA surveys (50-74%=$3; 75-89%=$5; ≥90%=$10) each week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ecological Momentary Assessment (EMA; Metricwire) Prompts 3x/day
2021
N/A
~40
Ecological Momentary Assessment (EMA; Metricwire) Prompts 6x/day
2021
N/A
~40
Incentive Structure - fixed
2021
N/A
~40
Incentive Structure - prize based
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Nationwide Children's HospitalLead Sponsor
341 Previous Clinical Trials
5,220,463 Total Patients Enrolled
Laura ChavezPrincipal InvestigatorAbigail Wexner Research Institute at Nationwide Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025